Anna Lok News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Although Black individuals with chronic hepatitis B were less likely to meet treatment criteria, researchers reported no significant differences in treatment initiation between racial groups, according to data in JAMA Network Open.“Because Asians and Blacks have higher prevalence of chronic HBV infection and are more likely to develop liver cancer, we examined whether there are racial

Prof. Stephan Urban led development of the first treatment for hepatitis D, an often-fatal infection for millions of people worldwide.

French program reveals good cure rates but also a high rate of modifications or discontinuations.

More than half of chronic hepatitis B e antigen–negative patients who withdraw from nucleoside or nucleotide analogue therapy experienced relapse within 4 years.

Target RWE Shares Weight Loss Data From Ongoing NASH Study Real-world study shows only 32% of overweight or obese adults with NAFLD in the U.S. achieved 5% or more weight reduction News provided by Share this article DURHAM, N.C., Feb. 2, 2021 /PRNewswire/ --  Target RWE, a leading real-world evidence (RWE) solutions company for the pharmaceutical and biotech industries, shared the latest data from the ongoing TARGET-NASH observational study, published in The nonalcoholic steatohepatitis (NASH) study, Weight Loss and Weight Regain in Usual Clinical Practice: Results from the TARGET-NASH Ob...